Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How does trastuzumab emtansine's patent expiry affect drug prices?What is the difference between apixaban and apixaban accord?Symbravo medication information ema europa eu?Can turmeric enhance lipitor's efficacy or side effects?Patent expiration eu dabrafenib?
See the DrugPatentWatch profile for vioxx
Vioxx was on the market for about 5 years, from its 1999 launch until it was withdrawn in 2004. The drug was pulled after safety concerns emerged, particularly related to cardiovascular risks. [1]
Merck withdrew Vioxx from the market in 2004 following findings and concerns that the medication increased the risk of heart attack and stroke compared with placebo/alternative treatments used at the time. [1]
“On the market” is typically described using the period when the product was actively sold (launch to withdrawal). For Vioxx, that sales window is generally reported as 1999–2004. [1]
After Vioxx’s withdrawal, patients and clinicians shifted toward other pain and inflammation options in the same general class (COX-2 inhibitors and/or other NSAIDs), but the specific alternatives varied by patient and risk profile. The key point is that Vioxx itself was no longer marketed after 2004. [1]
[1] https://en.wikipedia.org/wiki/Vioxx
Other Questions About Vioxx :